Cash Flow RaQualia Pharma, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-357.00
-294.00
851.00
880.00
-527.00
27.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
51.00
-460.00
643.00
-458.00
134.00
-686.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
180.00
-718.00
1,480.00
366.00
-289.00
-530.00
Cash Flow from Investing Activities
-3,665.00
-135.00
-47.00
-279.00
225.00
216.00
Cash Flow from Financing Activities
2,982.00
793.00
-29.00
-16.00
-6.00
695.00
Net Cash Inflow / Outflow
-522.00
-14.00
1,438.00
179.00
-138.00
370.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-20.00
45.00
35.00
109.00
-68.00
-10.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of RaQualia Pharma, Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
-357.732
-1208.349
851.00
70.39%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
51.96
-58.265
109.00
189.18%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
180.945
-1280.192
1,460.00
114.13%
Cash Flow from Investing Activities
-3665.61
0
-3,665.00
0.00%
Cash Flow from Financing Activities
2982.105
1538.27
1,444.00
93.86%
Net Cash Inflow / Outflow
-522.811
270.405
-792.00
-293.34%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-20.251
12.327
-32.00
-264.28%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 125.18% vs -148.55% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
180.94
-718.60
125.18%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
